Lifting the mask on neurological manifestations of COVID-19

2020/08/24 by Alessandro Pezzini, Alessandro Padovani · 1 voice · 472 citations
Medicine · Neuroscience · Psychology · #2019-20 coronavirus outbreak #COVID-19 Clinical Research Studies #Coronavirus #Coronavirus disease 2019 (COVID-19) #Disease #Epidemiology #Infectious disease (medical specialty) #Intensive care medicine #Long-Term Effects of COVID-19 #Medicine #Neuroimaging #Neuroscience #Outbreak #Pathology #Psychiatry #Psychology #SARS-CoV-2 and COVID-19 Research #Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

paper · pdf · doi:10.1038/s41582-020-0398-3

published in Nature Reviews Neurology 16(11), 636-644 (Nature Portfolio)

openalex publication_date 2020/08/24 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/29

Cited by

• SARS-CoV-2 infection causes dopaminergic neuron senescence
• Neurocardiac Autonomic Dysfunction in Patients With Post‐ COVID ‐19 Condition: A Systematic Review and Meta‐Analysis
• Brain 18F-fluorodeoxyglucose positron emission tomography/computed tomography in COVID 19–associated autoimmune encephalitis: a case report
• Post-viral fatigue in COVID-19: A review of symptom assessment methods, mental, cognitive, and physical impairment
• Functional disorders as a common motor manifestation of COVID‐19 infection or vaccination
• Long-Term Respiratory and Neurological Sequelae of COVID-19. [europepmc]
• Leukocyte trafficking to the lungs and beyond: lessons from influenza for COVID-19. [europepmc]
• Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology. [europepmc]
• Interrelations between COVID-19 and other disorders. [europepmc]
• Neurological issues in children with COVID-19. [europepmc]
• Post-COVID-19 Fatigue: Potential Contributing Factors. [europepmc]
• Rationally Designed ACE2-Derived Peptides Inhibit SARS-CoV-2. [europepmc]
• Neurological Manifestations of COVID-19 Feature T Cell Exhaustion and Dedifferentiated Monocytes in Cerebrospinal Fluid. [europepmc]
• Neuropathologic findings of patients with COVID-19: a systematic review. [europepmc]
• Selective Neuronal Mitochondrial Targeting in SARS-CoV-2 Infection Affects Cognitive Processes to Induce 'Brain Fog' and Results in Behavioral Changes that Favor Viral Survival. [europepmc]
• Cognitive decline among individuals with history of mild symptomatic SARS-CoV-2 infection: A longitudinal prospective study nested to a population cohort. [europepmc]
• Long-term microstructure and cerebral blood flow changes in patients recovered from COVID-19 without neurological manifestations. [europepmc]
• SARS-CoV-2 mediated neuroinflammation and the impact of COVID-19 in neurological disorders. [europepmc]
• The first 12 months of COVID-19: a timeline of immunological insights. [europepmc]
• Brain dysfunction in COVID-19 and CAR-T therapy: cytokine storm-associated encephalopathy. [europepmc]
• 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. [europepmc]
• Neurological and cognitive sequelae of Covid-19: a four month follow-up. [europepmc]
• SARS-CoV-2 Spike Targets USP33-IRF9 Axis via Exosomal miR-148a to Activate Human Microglia. [europepmc]
• Encephalitis as a neurological complication of COVID-19: A systematic review and meta-analysis of incidence, outcomes, and predictors. [europepmc]
• The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection. [europepmc]
• Post-traumatic stress symptoms in COVID-19 survivors: a self-report and brain imaging follow-up study. [europepmc]
• Mental Health Issues During and After COVID-19 Vaccine Era. [europepmc]
• Brain correlates of depression, post-traumatic distress, and inflammatory biomarkers in COVID-19 survivors: A multimodal magnetic resonance imaging study. [europepmc]
• Long COVID in hospitalized and non-hospitalized patients in a large cohort in Northwest Spain, a prospective cohort study. [europepmc]
• COVID-19 and cognitive impairment: neuroinvasive and blood‒brain barrier dysfunction. [europepmc]

Discussions

• Crucial paper #4 doi.org/10.1038/s415... [bsky, 44 points, 5 comments]